Kathryn A. Skelding

1.6k total citations
34 papers, 1.2k citations indexed

About

Kathryn A. Skelding is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Kathryn A. Skelding has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Oncology. Recurrent topics in Kathryn A. Skelding's work include Protein Kinase Regulation and GTPase Signaling (10 papers), Neuroscience and Neuropharmacology Research (7 papers) and Reproductive tract infections research (5 papers). Kathryn A. Skelding is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (10 papers), Neuroscience and Neuropharmacology Research (7 papers) and Reproductive tract infections research (5 papers). Kathryn A. Skelding collaborates with scholars based in Australia, United States and Iran. Kathryn A. Skelding's co-authors include Joshua S. Brzozowski, John A.P. Rostas, Olivia Taylor, Nicole M. Verrills, Darren R. Shafren, Richard D. Barry, Kenneth W. Beagley, Shisan Bao, Danica K. Hickey and Helen Jankowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Kathryn A. Skelding

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn A. Skelding Australia 19 679 197 177 172 125 34 1.2k
Marek Duszyk Canada 25 701 1.0× 188 1.0× 131 0.7× 129 0.8× 47 0.4× 61 1.6k
Claudia Sievers Germany 11 1.3k 1.9× 227 1.2× 214 1.2× 173 1.0× 73 0.6× 19 1.9k
Sergio Tripodi Italy 18 398 0.6× 284 1.4× 54 0.3× 131 0.8× 61 0.5× 60 1.1k
Renate Paddenberg Germany 21 603 0.9× 139 0.7× 147 0.8× 74 0.4× 79 0.6× 36 1.2k
Song‐Yi Yao United States 17 862 1.3× 502 2.5× 326 1.8× 237 1.4× 208 1.7× 23 1.8k
Sander H. Diks Netherlands 21 810 1.2× 166 0.8× 183 1.0× 191 1.1× 23 0.2× 46 1.4k
Marieluise Kirchner Germany 20 665 1.0× 106 0.5× 78 0.4× 42 0.2× 87 0.7× 48 1.2k
S Toyoshima Japan 20 464 0.7× 209 1.1× 195 1.1× 120 0.7× 32 0.3× 70 1.8k
Shubai Liu China 22 580 0.9× 211 1.1× 115 0.6× 139 0.8× 39 0.3× 45 1.2k
Philip R. Gafken United States 29 2.7k 4.0× 242 1.2× 236 1.3× 257 1.5× 161 1.3× 50 3.4k

Countries citing papers authored by Kathryn A. Skelding

Since Specialization
Citations

This map shows the geographic impact of Kathryn A. Skelding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn A. Skelding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn A. Skelding more than expected).

Fields of papers citing papers by Kathryn A. Skelding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn A. Skelding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn A. Skelding. The network helps show where Kathryn A. Skelding may publish in the future.

Co-authorship network of co-authors of Kathryn A. Skelding

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn A. Skelding. A scholar is included among the top collaborators of Kathryn A. Skelding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn A. Skelding. Kathryn A. Skelding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Enjeti, Anoop, et al.. (2025). Combination therapy in cancer: The potential of tetrandrine as a polytherapy for acute myeloid leukemia. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(4). 189377–189377. 1 indexed citations
2.
3.
4.
5.
Skelding, Kathryn A. & Lisa F. Lincz. (2021). PARP Inhibitors and Haematological Malignancies—Friend or Foe?. Cancers. 13(21). 5328–5328. 9 indexed citations
6.
Birgersson, Madeleine, Joshua S. Brzozowski, Jeffrey S. Brown, et al.. (2021). A Novel Role for Brain and Acute Leukemia Cytoplasmic (BAALC) in Human Breast Cancer Metastasis. Frontiers in Oncology. 11. 656120–656120. 3 indexed citations
7.
Lincz, Lisa F., et al.. (2020). Unlikely role of glycolytic enzyme ��-enolase in cancer metastasis and its potential as a prognostic biomarker. Journal of Cancer Metastasis and Treatment. 2020. 8 indexed citations
8.
Brzozowski, Joshua S. & Kathryn A. Skelding. (2019). The Multi-Functional Calcium/Calmodulin Stimulated Protein Kinase (CaMK) Family: Emerging Targets for Anti-Cancer Therapeutic Intervention. Pharmaceuticals. 12(1). 8–8. 66 indexed citations
9.
Skelding, Kathryn A. & John A.P. Rostas. (2019). Regulation of Multifunctional Calcium/Calmodulin Stimulated Protein Kinases by Molecular Targeting. Advances in experimental medicine and biology. 1131. 649–679. 12 indexed citations
10.
Brzozowski, Joshua S., Helen Jankowski, Danielle R. Bond, et al.. (2018). Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines. Lipids in Health and Disease. 17(1). 211–211. 120 indexed citations
11.
Brzozowski, Joshua S., Danielle R. Bond, Helen Jankowski, et al.. (2018). Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion. Scientific Reports. 8(1). 8822–8822. 64 indexed citations
12.
Rostas, John A.P., Neil J. Spratt, Phillip W. Dickson, & Kathryn A. Skelding. (2017). The role of Ca 2+ -calmodulin stimulated protein kinase II in ischaemic stroke – A potential target for neuroprotective therapies. Neurochemistry International. 107. 33–42. 17 indexed citations
13.
Evans, Hamish M., et al.. (2016). Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells. Scientific Reports. 6(1). 33132–33132. 48 indexed citations
14.
Dickson, Phillip W., et al.. (2014). Dephosphorylation of CaMKII at T253 controls the metaphase–anaphase transition. Cellular Signalling. 26(4). 748–756. 18 indexed citations
15.
Skelding, Kathryn A., et al.. (2014). Excitotoxic Stimulation of Brain Microslices as an <em>In vitro</em> Model of Stroke. Journal of Visualized Experiments. e51291–e51291. 3 indexed citations
16.
Skelding, Kathryn A., Tatsuo Suzuki, Jing Xue, et al.. (2010). Regulation of CaMKII by phospho-Thr253 or phospho-Thr286 sensitive targeting alters cellular function. Cellular Signalling. 22(5). 759–769. 21 indexed citations
17.
Skelding, Kathryn A., Richard D. Barry, & Darren R. Shafren. (2010). Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride. Investigational New Drugs. 30(2). 568–581. 35 indexed citations
18.
Skelding, Kathryn A. & John A.P. Rostas. (2009). Regulation of CaMKII In vivo: The Importance of Targeting and the Intracellular Microenvironment. Neurochemical Research. 34(10). 1792–1804. 34 indexed citations
19.
Skelding, Kathryn A., Richard D. Barry, & Darren R. Shafren. (2008). Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21. Breast Cancer Research and Treatment. 113(1). 21–30. 53 indexed citations
20.
Berry, Linda J., Danica K. Hickey, Kathryn A. Skelding, et al.. (2004). Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects againstChlamydia muridarumGenital Tract Infection. Infection and Immunity. 72(2). 1019–1028. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marek Duszyk Breakdown of academic impact, for papers by Claudia Sievers Breakdown of academic impact, for papers by Sergio Tripodi Breakdown of academic impact, for papers by Renate Paddenberg Breakdown of academic impact, for papers by Song‐Yi Yao Breakdown of academic impact, for papers by Sander H. Diks Breakdown of academic impact, for papers by Marieluise Kirchner Breakdown of academic impact, for papers by S Toyoshima Breakdown of academic impact, for papers by Shubai Liu Breakdown of academic impact, for papers by Philip R. Gafken
Rankless by CCL
2026